Delivery Order SPE2DB24D3014-SPE2DB26FKRXN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,247.31 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, was competitively awarded with no set-aside designation. This delivery order operates under a firm fixed price arrangement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,704.85 to AmerisourceBergen Drug Corp on August 11, 2025, for Lantus SoloStar 100 Unit/ML 3ML insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger indefinite delivery contract vehicle. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,201.44 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL) on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens valued at $1,278.50 on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens, valued at $1,309.92. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 26, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with completion targeted for October 31, 2025. This is a firm fixed price, non-set-aside award supporting federal medical procurement needs. The contract was issued on October 30, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,534.20 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled at the company's...
- The Defense Logistics Agency awarded a $2,045.86 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB26FKRXNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,278.50 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 7, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through the DLA's Medical Supply Chain, serving critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/6/25 |